Alixia Therapeutics

Alixia Therapeutics targets cancer drug resistance by disrupting metabolic shifts

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Alixia Therapeutics targets cancer drug resistance by disrupting metabolic shifts. The company's lead compounds aim for effective, lasting cancer treatment.

02Backed By1 investor

ZVZAKA VC→

03Similar Companies

A

Is this your company? Claim your profile

Actithera

Biotech & Life Sciences

→

AT

Avenzo Therapeutics

Biotech & Life Sciences

→

O

Oncko

Biotech & Life Sciences

→

AT

Antares Therapeutics

Biotech & Life Sciences

→

K

Kairos

Biotech & Life Sciences

→

04Startup DNA

8

signals

Sectors
Business Model
Technology